New drug approval : FDA needs to enhance its oversight of drugs approved on the basis of surrogate endpoints : report to the Ranking Member, Committee on Finance, U.S. Senate.

Bibliographic Details
Corporate Authors:	United States. Government Accountability Office, United States. Congress. Senate. Committee on Finance
Format:	Government Document eBook
Language:	English
Published:	[Washington, D.C.] : U.S. Govt. Accountability Office, [2009]
Subjects:	United States. > Food and Drug Administration. Drug approval > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS119688

Available Online